Govt panel approves use of Corbevax for 5-12 year age group
Expert panel of Drug Controller General of India -- India’s drug regulator-- has recommended granting emergency use authorisation for Biological E's Covid-19 vaccine Corbevax for children in 5 to 12 years age group. "The Subject Expert Committee on COVID-19 of the CDSCO which deliberated on Biological E's EUA application has recommended granting emergency use authorisation for use of Corbevax in the age group of five to 11 years," a source was quoted as saying by PTI. March, 2021: The next phase of Covid-19 vaccination commenced for people over 60 years of age and those aged 45 and above with specified co-morbid conditions. May, 2021: The government expanded its vaccination drive and allowed everyone above 18 years of age to be inoculated against coronavirus from May 1 last year.
India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs
COVID-19: India records over 12,000 fresh cases, active tally climbs to 67,556
Discover Related
Unified health coverage scheme rolled out in Odisha
Health Council: no COVID-19 vaccine needed for adults under 50 who get flu shot
A bad omen for public trust in vaccines
Karnataka launches adult BCG vaccination drive to combat TB
Karnataka government launches adult BCG vaccination drive to boost TB prevention
PMC urges private schools to support JE vaccination drive
Letters to The Editor — March 19, 2025
Immunising the elderly is crucial in disease prevention, say experts
National Vaccination Day 2025: Date, history, significance
India reports spike in seasonal flu, Delhi leads the list with 3,141 cases
India ramps up H5N1 containment after outbreak in Madhya Pradesh
India developing it’s first indigenously developed monkey fever KFD vaccine
Programme launched to vaccinate adolescent girls against cervical cancer